Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

April 30, 2005

Conditions
Hypertriglyceridemia
Interventions
DRUG

implitapide

Trial Locations (9)

45229

Metabolic and Atherosclerosis Research Center, Cincinnati

77030

The Methodist Hospital, Houston

1105 AZ

Academic Medical Center Amsterdam, Amsterdam

9711 SG

Andromed Noord, Groningen

2311 GZ

Andromed Leiden, Leiden

3021 HC

Andromed Rotterdam, Rotterdam

6883 HM

Andromed Oost, Velp

2724 EK

Andromed Zoetermeer, Zoetermeer

Unknown

Lipidklinikken - Rikshospitalet, Oslo

All Listed Sponsors
lead

Medical Research Laboratories International

INDUSTRY